Palisade Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.06M | Buy |
44,085
+3,250
| +8% | +$85K | 0.1% | 118 |
|
|
2026
Q1 | $1.15M | Sell |
40,835
-1,126
| -3% | -$30K | 0.12% | 110 |
|
|
2025
Q4 | $1.04M | Sell |
41,961
-1,305
| -3% | -$32.9K | 0.1% | 115 |
|
|
2025
Q3 | $1.1M | Sell |
43,266
-520
| -1% | -$12.8K | 0.1% | 112 |
|
|
2025
Q2 | $1.06M | Sell |
43,786
-4,200
| -9% | -$97.9K | 0.11% | 113 |
|
|
2025
Q1 | $1.22M | Sell |
47,986
-2,327
| -5% | -$60.9K | 0.12% | 107 |
|
|
2024
Q4 | $1.33M | Buy |
50,313
+78
| +0.2% | +$2.12K | 0.14% | 102 |
|
|
2024
Q3 | $1.45M | Buy |
50,235
+1,295
| +3% | +$37.8K | 0.14% | 101 |
|
|
2024
Q2 | $1.37M | Buy |
48,940
+5
| +0% | +$138 | 0.14% | 106 |
|
|
2024
Q1 | $1.36M | Buy |
48,935
+1,700
| +4% | +$47.2K | 0.13% | 110 |
|
|
2023
Q4 | $1.36M | Sell |
47,235
-4,095
| -8% | -$124K | 0.15% | 101 |
|
|
2023
Q3 | $1.7M | Buy |
51,330
+1,475
| +3% | +$52.2K | 0.21% | 88 |
|
|
2023
Q2 | $1.83M | Buy |
49,855
+300
| +0.6% | +$11.7K | 0.21% | 87 |
|
|
2023
Q1 | $2.02M | Buy |
49,555
+840
| +2% | +$36.3K | 0.25% | 85 |
|
|
2022
Q4 | $2.5M | Buy |
48,715
+425
| +0.9% | +$20.4K | 0.29% | 77 |
|
|
2022
Q3 | $2.11M | Sell |
48,290
-510
| -1% | -$24.8K | 0.29% | 77 |
|
|
2022
Q2 | $2.56M | Buy |
48,800
+1,340
| +3% | +$68.3K | 0.33% | 72 |
|
|
2022
Q1 | $2.46M | Buy |
47,460
+3,600
| +8% | +$187K | 0.28% | 76 |
|
|
2021
Q4 | $2.59M | Sell |
43,860
-1,950
| -4% | -$96.6K | 0.29% | 74 |
|
|
2021
Q3 | $1.97M | Buy |
45,810
+730
| +2% | +$32.3K | 0.24% | 80 |
|
|
2021
Q2 | $1.76M | Buy |
45,080
+1,494
| +3% | +$58.1K | 0.21% | 84 |
|
|
2021
Q1 | $1.58M | Sell |
43,586
-22,371
| -34% | -$794K | 0.2% | 88 |
|
|
2020
Q4 | $2.43M | Sell |
65,957
-2,481
| -4% | -$91K | 0.33% | 72 |
|
|
2020
Q3 | $2.38M | Hold |
68,438
| – | – | 0.36% | 71 |
|
|
2020
Q2 | $2.12M | Buy |
68,438
+3,030
| +5% | +$103K | 0.34% | 71 |
|
|
2020
Q1 | $2.03M | Buy |
65,408
+2,283
| +4% | +$77.8K | 0.37% | 68 |
|
|
2019
Q4 | $2.35M | Buy |
63,125
+2,480
| +4% | +$88.3K | 0.34% | 71 |
|
|
2019
Q3 | $2.07M | Buy |
60,645
+1,324
| +2% | +$48.1K | 0.32% | 72 |
|
|
2019
Q2 | $2.44M | Buy |
59,321
+186
| +0.3% | +$7.39K | 0.38% | 68 |
|
|
2019
Q1 | $2.38M | Buy |
59,135
+412
| +0.7% | +$16.5K | 0.38% | 69 |
|
|
2018
Q4 | $2.43M | Sell |
58,723
-26
| -0% | -$1.08K | 0.36% | 63 |
|
|
2018
Q3 | $2.46M | Buy |
58,749
+1,007
| +2% | +$38.8K | 0.32% | 67 |
|
|
2018
Q2 | $1.99M | Buy |
57,742
+1,317
| +2% | +$45K | 0.29% | 69 |
|
|
2018
Q1 | $1.9M | Hold |
56,425
| – | – | 0.29% | 71 |
|
|
2017
Q4 | $1.94M | Sell |
56,425
-105
| -0.2% | -$3.58K | 0.31% | 71 |
|
|
2017
Q3 | $1.92M | Buy |
56,530
+290
| +0.5% | +$9.32K | 0.35% | 63 |
|
|
2017
Q2 | $1.79M | Hold |
56,240
| – | – | 0.35% | 64 |
|
|
2017
Q1 | $1.82M | Buy |
56,240
+3,857
| +7% | +$122K | 0.34% | 57 |
|
|
2016
Q4 | $1.61M | Sell |
52,383
-474
| -0.9% | -$14.5K | 0.31% | 64 |
|
|
2016
Q3 | $1.7M | Hold |
52,857
| – | – | 0.32% | 64 |
|
|
2016
Q2 | $1.77M | Hold |
52,857
| – | – | 0.33% | 64 |
|
|
2016
Q1 | $1.49M | Buy |
52,857
+316
| +0.6% | +$9.03K | 0.29% | 70 |
|
|
2015
Q4 | $1.61M | Sell |
52,541
-316
| -0.6% | -$9.94K | 0.34% | 61 |
|
|
2015
Q3 | $1.57M | Hold |
52,857
| – | – | 0.35% | 66 |
|
|
2015
Q2 | $1.68M | Sell |
52,857
-456
| -0.9% | -$14.9K | 0.33% | 67 |
|
|
2015
Q1 | $1.76M | Buy |
53,313
+590
| +1% | +$18.8K | 0.35% | 64 |
|
|
2014
Q4 | $1.56M | Buy |
52,723
+253
| +0.5% | +$7.25K | 0.31% | 66 |
|
|
2014
Q3 | $1.47M | Buy |
52,470
+882
| +2% | +$24.8K | 0.3% | 68 |
|
|
2014
Q2 | $1.45M | Buy |
51,588
+33
| +0.1% | +$941 | 0.31% | 67 |
|
|
2014
Q1 | $1.57M | Hold |
51,555
| – | – | 0.34% | 60 |
|
|
2013
Q4 | $1.5M | Buy |
51,555
+527
| +1% | +$15.3K | 0.34% | 63 |
|
|
2013
Q3 | $1.39M | Sell |
51,028
-2,393
| -4% | -$65.1K | 0.35% | 62 |
|
|
2013
Q2 | $1.42M | Buy |
+53,421
| New | +$1.48M | 0.36% | 62 |
|
Other funds holding PFE
Palisade Asset Management's PFE Position: Q2 2026 in Review
Palisade Asset Management increased its Pfizer (PFE) stake by 8% in Q2 2026, buying an estimated $85K and bringing the position to 44,085 shares worth $1.06M. The position accounts for 0.1% of the portfolio, ranked #118.
Palisade Asset Management first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.59M in Q4 2021. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Palisade Asset Management held 44,085 shares of Pfizer worth $1.06M as of Q2 2026.
- Palisade Asset Management bought 3,250 Pfizer shares in Q2 2026, an estimated $85K.
- Pfizer made up 0.1% of Palisade Asset Management's portfolio in Q2 2026, its #118 holding.
- Palisade Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Palisade Asset Management's Pfizer position peaked at $2.59M in Q4 2021.
- 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Palisade Asset Management's 13F filing for Q2 2026, filed 20 Jul 2026.